Tech Company Financing Transactions
Mirexus Biotechnologies Funding Round
On 7/1/2017, Mirexus Biotechnologies announced $12 million in funding from GEL Tech.
Transaction Overview
Company Name
Announced On
7/1/2017
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The funds will be used to finance a factory to produce PhytoSpherix, and to fund at least three years of operations as the company grows.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
574 Hanlon Creek Blvd.
Guelph ON, N1C 0A1
Canada
Guelph ON, N1C 0A1
Canada
Phone
Website
Email Address
Overview
Mirexus Inc. is a safe and natural biomaterials company based in Guelph, Ontario that is commercializing a novel nanotechnology based on polysaccharide nanoparticles that can be used in a wide variety of markets ranging from cosmetics to nutraceuticals to biomedical applications in animal and human health.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Phil Whiting
Chief Financial Officer
Greg Stewart
Chief Scientific Officer
Anton Korenevski
VP - Bus. Development
Alison Crumblehulme
VP - Engineering
Trevor Jones
Browse more venture capital transactions:
Prev: 7/1/2017: Innovu venture capital transaction
Next: 7/1/2017: Motiv venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs